A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT02545283 · TERMINATED
Trial details
- NCT number
- NCT02545283
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2020-04-24
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.